Gene · 3482
Papers4,462
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,462
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Revisiting the neuroinflammation hypothesis in Alzheimer's disease: a focus on the druggability of current targets. | Front Pharmacol | 2023 | 37361208 | PubTator, text mining | PubMed |
| Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy. | Int J Cardiovasc Imaging | 2023 | 37358707 | PubTator, text mining | PubMed |
| Neurosarcomatous amelanotic transformation of malignant melanoma presenting as malignant periopheral nerve sheath tumor: Rare case report. | Medicine (Baltimore) | 2023 | 37352079 | PubTator, text mining | PubMed |
| Epigenetics and the Exposome: DNA Methylation as a Proxy for Health Impacts of Prenatal Environmental Exposures. | Exposome | 2023 | 37333730 | PubTator, text mining | PubMed |
| Subcellular spatially resolved gene neighborhood networks in single cells. | Cell Rep Methods | 2023 | 37323566 | PubTator, text mining | PubMed |
| Architecture of the ESCPE-1 membrane coat. | Nat Struct Mol Biol | 2023 | 37322239 | PubTator, text mining | PubMed |
| Regulation of whole-transcriptome sequencing expression in COPD after personalized precise exercise training: a pilot study. | Respir Res | 2023 | 37312153 | PubTator, text mining | PubMed |
| Proteogenomic landscape of gastric adenocarcinoma peritoneal metastases. | iScience | 2023 | 37305699 | PubTator, text mining | PubMed |
| M6P-modified solid lipid nanoparticles loaded with matrine for the treatment of fibrotic liver. | Drug Deliv | 2023 | 37300371 | PubTator, text mining | PubMed |
| Canine Mammary Neoplasia Induces Variations in the Peripheral Blood Levels of CD20, CD45RA, and CD99. | Int J Mol Sci | 2023 | 37298173 | PubTator, text mining | PubMed |
| Pathways Related to Colon Inflammation Are Associated with Colorectal Carcinoma: A Transcriptome- and Methylome-Wide Study. | Cancers (Basel) | 2023 | 37296884 | PubTator, text mining | PubMed |
| Engineered extracellular matrices facilitate brain organoids from human pluripotent stem cells. | Ann Clin Transl Neurol | 2023 | 37283238 | PubTator, text mining | PubMed |
| Enhancement of lysosome biogenesis as a potential therapeutic approach for neurodegenerative diseases. | Neural Regen Res | 2023 | 37282455 | PubTator, text mining | PubMed |
| The tobacco-specific carcinogen NNK induces pulmonary tumorigenesis via nAChR/Src/STAT3-mediated activation of the renin-angiotensin system and IGF-1R signaling. | Exp Mol Med | 2023 | 37258578 | PubTator, text mining | PubMed |
| Enzyme replacement with transferrin receptor-targeted α-L-iduronidase rescues brain pathology in mucopolysaccharidosis I mice. | Mol Ther Methods Clin Dev | 2023 | 37251981 | PubTator, text mining | PubMed |
| A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer. | Mol Cancer | 2023 | 37248468 | PubTator, text mining | PubMed |
| Multi-omic approach characterises the neuroprotective role of retromer in regulating lysosomal health. | Nat Commun | 2023 | 37248224 | PubTator, text mining | PubMed |
| Juvenile CLN3 disease is a lysosomal cholesterol storage disorder: similarities with Niemann-Pick type C disease. | EBioMedicine | 2023 | 37245481 | PubTator, text mining | PubMed |
| PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies. | Molecules | 2023 | 37241755 | PubTator, text mining | PubMed |
| Neurotensin and Alcohol Use Disorders: Towards a Pharmacological Treatment. | Int J Mol Sci | 2023 | 37240004 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3482/papers?page=19